SCHEMBL19956743

SCHEMBL19956743

Cc1ccc(C2CCC(CP(C)(=O)OC(C)C)CC2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.35
MAPT P10636 3/20 0.35
LMNA P02545 2/20 0.35
KDM4E B2RXH2 2/20 0.34
POLB P06746 1/20 0.34
CYP2C9 P11712 2/20 0.33
ESR2 Q92731 2/20 0.33
ESR1 P03372 1/20 0.33
CYP3A4 P08684 1/20 0.33
DGAT1 O75907 3/20 0.33
CCR1 P32246 1/20 0.33
GRIA4 P48058 1/20 0.32
TP53 P04637 1/20 0.32
ATM Q13315 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
LIPE Q05469 1/20 0.32
P2RX3 P56373 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22415454 0.77 ESR2 (0.40) ALDH1A1MAPTLMNACYP2C9ESR2
SCHEMBL19956767 0.76 DGAT1 (0.48) ALDH1A1MAPTLMNACYP2C9ESR2
SCHEMBL19956739 0.76 DGAT1 (0.48) ALDH1A1MAPTLMNACYP2C9ESR2
SCHEMBL19956786 0.72 SPHK1 (0.40) ALDH1A1MAPTLMNACYP2C9
SCHEMBL19956766 0.71 ALDH1A1 (0.39) ALDH1A1MAPTLMNACYP2C9ESR2
SCHEMBL1405569 0.69 ESR2 (0.50) ALDH1A1MAPTLMNAPOLBCYP2C9
SCHEMBL10607267 0.68 ESR2 (0.46) ALDH1A1MAPTLMNACYP2C9ESR2
SCHEMBL11284288 0.67 ESR2 (0.39) CYP2C9ESR2ESR1CYP3A4DGAT1
SCHEMBL15698271 0.67 HPGD (0.45) ALDH1A1MAPTLMNAESR2CCR1
SCHEMBL14959893 0.67 ESR2 (0.44) ALDH1A1MAPTLMNACYP2C9ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2805951-B1 Inhibitors of diacylglycerol o-acyltransferase 1 (DGAT-1) and uses thereof METABASIS THERAPEUTICS INC (US) 2018-03-14 EP disclosed